Risperidone-associated	risperidone-associated	O	O
,	,	O	O
benign	benign	O	O
transient	transient	O	O
visual	visual	O	O
disturbances	disturbances	O	O
in	in	O	O
schizophrenic	schizophrenic	O	O
patients	patients	O	O
with	with	O	O
a	a	O	O
past	past	O	O
history	history	O	O
of	of	O	O
LSD	lsd	S_chemicals	O
abuse	abuse	O	O
.	.	O	O

Two	two	O	O
schizophrenic	schizophrenic	O	O
patients	patients	O	O
,	,	O	O
who	who	O	O
had	had	O	O
a	a	O	O
prior	prior	O	O
history	history	O	O
of	of	O	O
LSD	lsd	S_chemicals	O
abuse	abuse	O	O
and	and	O	O
who	who	O	O
had	had	O	O
previously	previously	O	O
developed	developed	O	O
EPS	eps	O	O
with	with	O	O
classic	classic	O	O
antipsychotics	antipsychotics	S_chemicals	O
,	,	O	O
were	were	O	O
successfully	successfully	O	O
treated	treated	O	O
with	with	O	O
risperidone	risperidone	O	O
.	.	O	O

They	they	O	O
both	both	O	O
reported	reported	O	O
short	short	O	O
episodes	episodes	O	O
of	of	O	O
transient	transient	O	O
visual	visual	O	O
disturbances	disturbances	O	O
,	,	O	O
which	which	O	O
appeared	appeared	O	O
immediately	immediately	O	O
after	after	O	O
starting	starting	O	O
treatment	treatment	O	O
with	with	O	O
risperidone	risperidone	O	O
.	.	O	O

This	this	O	O
imagery	imagery	O	O
resembled	resembled	O	O
visual	visual	O	O
disturbances	disturbances	O	O
previously	previously	O	O
experienced	experienced	O	O
as	as	O	O
"	"	O	O
flashbacks	flashbacks	O	O
"	"	O	O
related	related	O	O
to	to	O	O
prior	prior	O	O
LSD	lsd	S_chemicals	O
consumption	consumption	O	O
.	.	O	O

Risperidone	risperidone	O	O
administration	administration	O	O
was	was	O	O
continued	continued	O	O
and	and	O	O
the	the	O	O
visual	visual	O	O
disturbances	disturbances	O	O
gradually	gradually	O	O
wore	wore	O	O
off	off	O	O
.	.	O	O

During	during	O	O
a	a	O	O
six-month	six-month	O	O
follow-up	follow-up	O	O
period	period	O	O
,	,	O	O
there	there	O	O
was	was	O	O
no	no	O	O
recurrence	recurrence	O	S_disease
of	of	O	O
visual	visual	O	O
disturbances	disturbances	O	O
.	.	O	O

This	this	O	O
phenomenon	phenomenon	O	O
may	may	O	O
be	be	O	O
interpreted	interpreted	O	O
as	as	O	O
a	a	O	O
benign	benign	O	O
,	,	O	O
short-term	short-term	O	O
and	and	O	O
self-limiting	self-limiting	O	O
side	side	O	B_disease
effect	effect	O	I_disease
which	which	O	O
does	does	O	O
not	not	O	O
contraindicate	contraindicate	O	O
the	the	O	O
use	use	O	O
of	of	O	O
risperidone	risperidone	O	O
or	or	O	O
interfere	interfere	O	O
with	with	O	O
treatment	treatment	O	O
.	.	O	O

Conclusions	conclusions	O	O
based	based	O	O
on	on	O	O
two	two	O	O
case	case	O	O
reports	reports	O	O
should	should	O	O
be	be	O	O
taken	taken	O	O
with	with	O	O
appropriate	appropriate	O	O
caution	caution	O	O
.	.	O	O

